Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Alessandra OlivaA CurtoloL VolpicelliF CancelliC BorrazzoF Cogliati DezzaG MarcelliF GavaruzziS Di BariP RicciO TurrizianiC M MastroianniM VendittiPublished in: Infection (2022)
An underlying haematological malignancy was associated with a worse clinical outcome in COVID-19 patients. A prolonged clinical monitoring is needed, since respiratory worsening may occur later during hospitalization.